Premier Alternatives

Conceivable Life Sciences

New York, NY · Founded 2022 · Privately Held (backing)

Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments. Conceivable Life Sciences is based in New York, NY and was founded in 2022. It was valued at $145 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $88.5 million across 3 recorded rounds; the latest was a $30.5 million early-stage round in Aug 2025.

PMV mark · valuation
$145.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$88.5M
Last round
Early Stage VC
Aug 2025

Conceivable Life Sciences key facts

as of Oct 2026
  • Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments.
  • Conceivable Life Sciences is valued at approximately $145.0M as of Oct 2026, set at its early-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $88.5M across 3 recorded rounds; the latest was Early Stage VC ($30.5M) in Aug 2025.
  • Notable investors include ACME Capital, Advance Venture Partners, Muse Capital, Black Opal Ventures, Time BioVentures — 13 tracked in total.
  • Conceivable Life Sciences has filed 4 Form Ds with the SEC since 2023, most recently Sep 2025 ($30.5M sold to 20 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$145.0M

Valued at $145.0M at its early-stage round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Conceivable Life Sciences with a free account
  • ·The complete investor list: 13 names
  • ·Watch Conceivable Life Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Conceivable Life Sciences funding rounds

3 rounds
Aug 2025Early Stage VC$30.5MSEC filing▮
Nov 2024Debt$16.0MSEC filing▮
Jul 2023Early Stage VC$17.0MSEC filing▮
Full funding history →

Conceivable Life Sciences valuation

Conceivable Life Sciences was valued at $145 million at its early-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Conceivable Life Sciences raised?

Conceivable Life Sciences has raised $88.5 million across 3 recorded rounds since 2023. The largest was a $30.5 million early-stage round in Aug 2025.

Conceivable Life Sciences has filed 4 Form Ds with the SEC since 2023, most recently in Sep 2025 ($30.5 million sold to 20 investors).

Conceivable Life Sciences investors

13 investors are on record for Conceivable Life Sciences, including ACME Capital, Advance Venture Partners, Muse Capital and Black Opal Ventures. The early-stage round in Aug 2025 drew 20 investors.

About Conceivable Life Sciences

Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments. The company offers an integrated platform that handles all IVF lab functions, including sperm processing, egg preparation, and incubation, enabling individuals facing infertility to access consistent and safer fertility care.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2022
Employees
48
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.